BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33261630)

  • 1. miR-29c-3p regulates proliferation and migration in ovarian cancer by targeting KIF4A.
    Feng S; Luo S; Ji C; Shi J
    World J Surg Oncol; 2020 Dec; 18(1):315. PubMed ID: 33261630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-29c-3p, a target miRNA of LINC01296, accelerates tumor malignancy: therapeutic potential of a LINC01296/miR-29c-3p axis in ovarian cancer.
    Xu H; Mao HL; Zhao XR; Li Y; Liu PS
    J Ovarian Res; 2020 Mar; 13(1):31. PubMed ID: 32192508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-379-5p inhibits the proliferation, migration, and invasion of breast cancer by targeting KIF4A.
    Yang K; Li D; Jia W; Song Y; Sun N; Wang J; Li H; Yin C
    Thorac Cancer; 2022 Jul; 13(13):1916-1924. PubMed ID: 35608059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-574-3p exerts as a tumor suppressor in ovarian cancer through inhibiting MMP3 expression.
    Zheng J; Zhou Y; Li XJ; Hu JM
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6839-6848. PubMed ID: 31486483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of miR-493-3p suppresses ovarian cancer cell proliferation, migration and invasion through downregulating DPY30.
    Liu Q; Yang H; Hua H
    Reprod Biol; 2022 Jun; 22(2):100610. PubMed ID: 35313261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-29c-3p Suppresses the Migration, Invasion and Cell Cycle in Esophageal Carcinoma via CCNA2/p53 Axis.
    Wang H; Fu L; Wei D; Wang B; Zhang C; Zhu T; Ma Z; Li Z; Wu Y; Yu G
    Front Bioeng Biotechnol; 2020; 8():75. PubMed ID: 32154226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-29c-3p/C1QTNF6 Restrains the Angiogenesis and Cell Proliferation, Migration and Invasion in Head and Neck Squamous Cell Carcinoma.
    Huang F; Qi H
    Mol Biotechnol; 2023 Jun; 65(6):913-921. PubMed ID: 36348139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-29c-3p inhibits autophagy and cisplatin resistance in ovarian cancer by regulating FOXP1/ATG14 pathway.
    Hu Z; Cai M; Zhang Y; Tao L; Guo R
    Cell Cycle; 2020 Jan; 19(2):193-206. PubMed ID: 31885310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory mechanism of lncRNA NORAD on proliferation and invasion of ovarian cancer cells through miR-199a-3p.
    Xu C; Zhu LX; Sun DM; Yao H; Han DX
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1672-1681. PubMed ID: 32141533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-149-3p promotes the cisplatin resistance and EMT in ovarian cancer through downregulating TIMP2 and CDKN1A.
    Wang J; Liu L
    J Ovarian Res; 2021 Nov; 14(1):165. PubMed ID: 34798882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of long non-coding RNA XIST upregulates microRNA-149-3p to repress ovarian cancer cell progression.
    Jiang R; Zhang H; Zhou J; Wang J; Xu Y; Zhang H; Gu Y; Fu F; Shen Y; Zhang G; Feng L; Zhang X; Chen Y; Shen F
    Cell Death Dis; 2021 Feb; 12(2):145. PubMed ID: 33542185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-203a-3p regulates the biological behaviors of ovarian cancer cells through mediating the Akt/GSK-3β/Snail signaling pathway by targeting ATM.
    Liu HY; Zhang YY; Zhu BL; Feng FZ; Zhang HT; Yan H; Zhou B
    J Ovarian Res; 2019 Jul; 12(1):60. PubMed ID: 31277702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA TUG1 facilitates cell ovarian cancer progression through targeting MiR-29b-3p/MDM2 axis.
    Yang X; Xin N; Qu HJ; Wei L; Han Z
    Anat Rec (Hoboken); 2020 Dec; 303(12):3024-3034. PubMed ID: 31930662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-134-3p inhibits ovarian cancer progression by targeting flap structure-specific endonuclease 1 in vitro.
    Zhao M; Ji H; Fu Q; Cheng Q; Zhang Y; Yang Y
    Oncol Rep; 2021 Jan; 45(1):119-128. PubMed ID: 33169800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
    Hao T; Huang S; Han F
    Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-29c-3p inhibits epithelial-mesenchymal transition to inhibit the proliferation, invasion and metastasis of cervical cancer cells by targeting SPARC.
    Zou T; Gao Y; Qie M
    Ann Transl Med; 2021 Jan; 9(2):125. PubMed ID: 33569427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on the Function and Mechanism of miR-585-3p Inhibiting the Progression of Ovarian Cancer Cells by Targeting FSCN1 to Block the MAPK Signaling Pathway.
    Jia Y; Li J; Wang J; Luo T; Jing X; Zhao H
    Anal Cell Pathol (Amst); 2022; 2022():1732365. PubMed ID: 35602576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-29c functions as a tumor suppressor by targeting VEGFA in lung adenocarcinoma.
    Liu L; Bi N; Wu L; Ding X; Men Y; Zhou W; Li L; Zhang W; Shi S; Song Y; Wang L
    Mol Cancer; 2017 Feb; 16(1):50. PubMed ID: 28241836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA-324-3p suppresses the aggressive ovarian cancer by targeting
    Li F; Liang Z; Jia Y; Zhang P; Ling K; Wang Y; Liang Z
    Bioengineered; 2022 May; 13(5):12030-12044. PubMed ID: 35549643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA miR-330-3p suppresses the progression of ovarian cancer by targeting RIPK4.
    Cai L; Ye L; Hu X; He W; Zhuang D; Guo Q; Shu K; Jie Y
    Bioengineered; 2021 Dec; 12(1):440-449. PubMed ID: 33487072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.